Skip to main content

C393 (Deferasirox 360 mg)

Pill with imprint C393 is Pink, Capsule-shape and has been identified as Deferasirox 360 mg. It is supplied by Cipla USA, Inc.

Deferasirox is used in the treatment of thalassemia; iron overload; hemosiderosis and belongs to the drug class chelating agents. Risk cannot be ruled out during pregnancy. Deferasirox 360 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C393

Deferasirox 360 mg C393

Deferasirox

Imprint
C393
Strength
360 mg
Color
Pink
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Chelating agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA, Inc
National Drug Code (NDC)
69097-0393

Get help with Imprint Code FAQs.

Related Images for "C393"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.